NxStage Medical, Inc., a leading medical technology company focused on advancing renal care, today announced a three-year agreement with Satellite Healthcare that includes NxStage’s innovative Nx2me Connected Health® platform for their patients performing home hemodialysis (“HHD”) therapy with the NxStage® System One™. Satellite Healthcare is a national not-for-profit and the sixth largest provider of patient-centered dialysis and kidney disease services in the U.S. Under this agreement, Satellite will roll-out the Nx2me Connected Health platform to their HHD patients to enhance patient outcomes and clinician care.
A key component of the Nx2me platform is the Nx2me iPad app, which is designed to increase patients’ ease of use of home therapy by monitoring and capturing treatment data and wirelessly sending it to their center after each treatment. Dialysis center staff can access the treatment data using the Nx2me Clinician Portal to review and follow treatment adherence and progress. Importantly, Nx2me patient treatment data can be easily integrated into EMR systems, thereby reducing the need for paper flow sheets. By enhancing the ease of information collection and availability to the patient and care team, Nx2me has been shown to help improve patient retention on HHD. Recent data showed a 44% lower therapy discontinuation rate in new patients using the Nx2me iPad app1.
“This partnership strengthens our Re-Imagine Home goal to change the landscape of home dialysis with the design of an industry-leading home dialysis model,” said Satellite Healthcare CEO Rick Barnett. “We identified a number of ways to empower patients, including how technology like Nx2me can be a leading factor in removing barriers to choosing and staying with home dialysis.”
“We’re delighted that our depth of experience and investment in breakthrough technologies like Nx2me allow us to give Satellite Healthcare additional tools to optimize the way they provide personal care to their patients. We’ve had a long, successful relationship with Satellite, and are excited to extend the partnership to help Satellite continue to lead by example in the care of home dialysis patients,” said Joseph E. Turk, president of NxStage.
For more information about Nx2me and HHD with the NxStage System One, please visit NxStage.com
Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
1. Weinhandl E, Molina J, Collins A. Lower Risk of Home Hemodialysis Attrition in Patients Using Nx2me Connected Health Technology. Abstract presented at Annual Dialysis Conference. February, 2016.